ABBVIE INC. (ABBV)

Clinical trial NCT06575192 updates: 1. completion date: 2029-12-01 → 2031-02-01 2. primary completion date: 2029-12-01 → 2031-02-01 3. enrollment: 783 → 264 participants 4. allocation: NON_RANDOMIZED → NA 5. intervention model: PARALLEL → SINGLE_GROUP

ABBOTT LABORATORIES (ABT)

Clinical trial NCT06676072 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-04-30 → 2026-04-13 3. primary completion date: 2026-04-30 → 2026-04-13 4. enrollment type: ESTIMATED → ACTUAL 5. allocation: NON_RANDOMIZED → NA